BlackRock Amends MEDIFAST Stake, Signals Passive Investment Update
Ticker: MED · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 910329
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, portfolio-update
TL;DR
**BlackRock updated its passive stake in MEDIFAST, signaling a portfolio adjustment.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating a change in their ownership of MEDIFAST INC common stock as of December 31, 2023. This filing, Amendment No. 17, updates their previous disclosures regarding their passive investment in the health and wellness company. This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal shifts in their confidence or strategy regarding MEDIFAST, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's updated position in MEDIFAST, which can influence market perception and investor confidence in the stock.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor, indicating a passive investment, not an activist one.
Analyst Insight
Investors should note BlackRock's continued passive interest in MEDIFAST, but this filing alone doesn't suggest an immediate buy or sell action. It's a routine update from a large institutional holder.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- MEDIFAST INC (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 17 (number) — the specific amendment number of this filing
Forward-Looking Statements
- BlackRock will continue to hold a significant, but passive, stake in MEDIFAST INC. (BlackRock Inc.) — high confidence, target: Q1 2025
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, indicating a change in beneficial ownership by a passive investor.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., a major institutional investment manager.
What is the subject company of this filing?
The subject company is MEDIFAST INC, identified by the CIK 0000910329 and CUSIP 58470H101.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), which typically applies to institutional investors who acquire beneficial ownership of more than 5% of a class of equity securities in the ordinary course of business and without the purpose or effect of changing or influencing control of the issuer.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding MEDIFAST INC (MED).